Announcements Trials
Browse Landscape

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Turcot syndrome 1Lymphatic Metastasis 1

Interventions

Drug Therapy 107Cisplatin 98Radiotherapy 89Carboplatin 86Bevacizumab 79Oxaliplatin 74Capecitabine 69tislelizumab 68Gemcitabine 64Cyclophosphamide 64toripalimab 62Paclitaxel 58pembrolizumab 56Specimen Handling 54sintilimab 53Surgical Procedures, Operative 52anlotinib 51Magnetic Resonance Spectroscopy 50Fluorouracil 49Immune Checkpoint Inhibitors 43Blood Specimen Collection 42130-nm albumin-bound paclitaxel 42Standard of Care 38camrelizumab 36fludarabine 35Leucovorin 34lenvatinib 33venetoclax 30Radiosurgery 30Immunotherapy 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × DNA Mismatch Repair × Clear all
NCT07625735 2026-06-04

MMR Status Modulates the Predictive Value of Lymphatic Invasion for Lymph Node Metastasis in Gastric Cancer

Shanghai Zhongshan Hospital

Not yet recruiting
3,000 enrolled

Turcot syndrome, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡